Antibody formation against GLP-1 medications can occasionally occur, though this is more common with exenatide than with human GLP-1 analogues like liraglutide or semaglutide
Important Notice This product is supplied for qualified laboratory research and analytical applications only
All these trials were designed to evaluate the primary outcome of 3-MACE defined as cardiovascular death, nonfatal myocardial infarct, and nonfatal stroke, except for the ELIXA trial of exenatide ER, which included hospitalization for unstable angina as an additional component of the 4-MACE composite outcomes
Athletes can confirm a product batch has been tested by searching by batch number, product name, or brand name on Informed-Sport.com
People with the following conditions should avoid using Ozempic: Pancreatitis Type 1 diabetes Being under 18 years of age Pregnancy or breastfeeding Diabetic retinopathy Pancreatic or kidney issues Family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a condition affecting the endocrine system